The chance of cancer one year after a normal TCT test is uncertain. The rate of cancer is not related to the TCT test program, which is a method of screening for cervical cancer.
Cervical TCT test is cervical liquid-based thin-layer cell test, that is, a small brush is first rotated on the surface of the cervical opening, so that the cervical shed cells can be collected, and then the collected shed cells under the microscope, to observe whether there are any abnormalities in these shed cells.TCT test is an effective method of screening cervical pre-cancerous lesions.
The size of the chance of causing cervical cancer depends on whether the patient is accompanied by human papillomavirus (HPV) infection. Once HPV16 and 18 are positive, it is necessary to review the test once every three to six months or so, and the chances of these two types of viruses leading to cervical cancer account for more than seventy percent of all cervical cancers.
TCT test is normal, HPV virus carriers, need to be under the guidance of the doctor for regular review, to prevent pre-cancerous lesions.